Table 3. Comparison of diagnostic measures between DQ and patient documentation based on patient population.
Diagnostic measures | Patients recruited by physicians who reported use of the measure | Patients in whom the measures were performed | |||
Physicians who reported routine use of the measure | Physicians who reported not to routinely use the measure | ||||
N = 249 (%) | % of patients | % of patients | P-value * | ||
Body plethysmography | 249 (100) | 72.7 | – | – ** | |
Chest X-ray | 242 (97.2) | 41.7 | 0 | 0.0436 | |
Spirometry | 211 (84.7) | 30.3 | 34.2 | 0.7035 | |
COPD Assessment Test | 199 (79.9) | 67.8 | 38.0 | 0.0002 | |
AATD screening | 210 (84.3) | 1.0 | 7.7 | 0.0285 | |
Differential blood count | 203 (81.5) | 6.9 | 6.7 | 0.3171 | |
Blood eosinophils | 192 (77.1) | 8.3 | 3.5 | 0.3801 | |
Total IgE | 199 (79.9) | 5.5 | 0 | 0.1274 | |
Specific IgE | 197 (79.1) | 4.6 | 0 | 0.2107 | |
Medical examination of the skin | 185 (74.3) | 3.2 | 4.7 | 0.6981 | |
CT-scan of thorax | 183 (73.5) | 6.6 | 4.5 | 0.7652 | |
mMRC (dyspnea assessment test) | 107 (43.0) | 50.5 | 0.7 | < 0.0001 |
AATD = alpha-1 antitrypsin deficiency; CT = computed tomography; DQ = doctor’s questionnaire; IgE = immunoglobulin E
Fisher’s exact test
could not be calculated for this specific comparison